Author: admin

  • Liverpool fury at ‘insulting’ BBC Kelvin MacKenzie interview

    Liverpool fury at ‘insulting’ BBC Kelvin MacKenzie interview

    Jonny HumphriesNorth West

    Peter Macdiarmid/Getty Images Kelvin MacKenzie, who has white hair and wears a white shirt, tie, and navy suit, walks on a street with the background blurred out. Peter Macdiarmid/Getty Images

    Kelvin MacKenzie was editor of The Sun newspaper when it ran false allegations against Liverpool fans in 1989

    A Hillsborough disaster survivor has reacted with fury to the BBC’s decision to…

    Continue Reading

  • McCown PJ, Ruszkowska A, Kunkler CN, Breger K, Hulewicz JP, Wang MC, et al. Naturally occurring modified ribonucleosides. WIREs RNA. 2020;11:e1595.

    CAS 
    PubMed 

    Google Scholar 

  • Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518:560–4.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • He PC, Wei J, Dou X, Harada BT, Zhang Z, Ge R, et al. Exon architecture controls mRNA m(6)A suppression and gene expression. Science. 2023;379:677–82.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu J, Dou X, Chen C, Chen C, Liu C, Xu MM, et al. N (6)-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science. 2020;367:580–6.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Xu W, Li J, He C, Wen J, Ma H, Rong B, et al. METTL3 regulates heterochromatin in mouse embryonic stem cells. Nature. 2021;591:317–21.

    CAS 
    PubMed 

    Google Scholar 

  • Wei J, Yu X, Yang L, Liu X, Gao B, Huang B, et al. FTO mediates LINE1 m(6)a demethylation and chromatin regulation in mESCs and mouse development. Science. 2022;376(6596):968–73.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346–9.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. 2017. https://doi.org/10.7554/eLife.31311.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu C, Dou X, Zhao Y, Zhang L, Zhang L, Dai Q, et al. IGF2BP3 promotes mRNA degradation through internal m(7)g modification. Nat Commun. 2024;15:7421.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117–20.

    PubMed 

    Google Scholar 

  • Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, Peer E, Kol N, Ben-Haim MS, et al. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016;530:441–6.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388–99.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–6.

    CAS 
    PubMed 

    Google Scholar 

  • Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell. 2012;149:1635–46.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Li Y, Wang Y, Vera-Rodriguez M, Lindeman LC, Skuggen LE, Rasmussen EMK, et al. Single-cell m(6)A mapping in vivo using picoMeRIP-seq. Nat Biotechnol. 2024;42:591–6.

    CAS 
    PubMed 

    Google Scholar 

  • Yao H, Gao CC, Zhang D, Xu J, Song G, Fan X, et al. Scm(6)A-seq reveals single-cell landscapes of the dynamic m(6)A during oocyte maturation and early embryonic development. Nat Commun. 2023;14:315.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hamashima K, Wong KW, Sam TW, Teo JHJ, Taneja R, Le MTN, et al. Single-nucleus multiomic mapping of m(6)A methylomes and transcriptomes in native populations of cells with sn-m6A-CT. Mol Cell. 2023. https://doi.org/10.1016/j.molcel.2023.08.010.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • McIntyre ABR, Gokhale NS, Cerchietti L, Jaffrey SR, Horner SM, Mason CE. Limits in the detection of m6A changes using MeRIP/m6A-seq. Sci Rep. 2020;10:6590.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hu L, Liu S, Peng Y, Ge R, Su R, Senevirathne C, et al. M(6)a RNA modifications are measured at single-base resolution across the mammalian transcriptome. Nat Biotechnol. 2022;40:1210–9.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu C, Sun H, Yi Y, Shen W, Li K, Xiao Y, et al. Absolute quantification of single-base m(6)A methylation in the mammalian transcriptome using GLORI. Nat Biotechnol. 2023;41:355–66.

    CAS 
    PubMed 

    Google Scholar 

  • Shen W, Sun H, Liu C, Yi Y, Hou Y, Xiao Y, et al. Glori for absolute quantification of transcriptome-wide m(6)a at single-base resolution. Nat Protoc. 2024;19:1252–87.

    CAS 
    PubMed 

    Google Scholar 

  • Li X, Xiong X, Zhang M, Wang K, Chen Y, Zhou J, et al. Base-Resolution Mapping Reveals Distinct m(1)A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts. Mol Cell. 2017;68(993–1005):e1009.

    Google Scholar 

  • Zhou H, Rauch S, Dai Q, Cui X, Zhang Z, Nachtergaele S, et al. Evolution of a reverse transcriptase to map N(1)-methyladenosine in human messenger RNA. Nat Methods. 2019;16:1281–8.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Pajdzik K, Lyu R, Dou X, Ye C, Zhang LS, Dai Q, et al. Chemical manipulation of m(1)A mediates its detection in human tRNA. RNA. 2024;30:548–59.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ge R, Ye C, Peng Y, Dai Q, Zhao Y, Liu S, et al. M(6)A-SAC-seq for quantitative whole transcriptome m(6)a profiling. Nat Protoc. 2023;18:626–57.

    CAS 
    PubMed 

    Google Scholar 

  • Xu H, Kong L, Cheng J, Al Moussawi K, Chen X, Iqbal A, et al. Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome. Nat Methods. 2024. https://doi.org/10.1038/s41592-024-02439-8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang M, Jiang Z, Ma Y, Liu W, Zhuang Y, Lu B, et al. Quantitative profiling of pseudouridylation landscape in the human transcriptome. Nat Chem Biol. 2023;19:1185–95.

    CAS 
    PubMed 

    Google Scholar 

  • Dai Q, Ye C, Irkliyenko I, Wang Y, Sun HL, Gao Y, et al. Ultrafast bisulfite sequencing detection of 5-methylcytosine in DNA and RNA. Nat Biotechnol. 2024. https://doi.org/10.1038/s41587-023-02034-w.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lu L, Zhang X, Zhou Y, Shi Z, Xie X, Zhang X, et al. Base-resolution m(5)C profiling across the mammalian transcriptome by bisulfite-free enzyme-assisted chemical labeling approach. Mol Cell. 2024;84(2984–3000):e2988.

    Google Scholar 

  • Marchand V, Ayadi L, Ernst FGM, Hertler J, Bourguignon-Igel V, Galvanin A, et al. Alkaniline-seq: profiling of m(7) G and m(3) C RNA modifications at single nucleotide resolution. Angew Chem Int Ed Engl. 2018;57:16785–90.

    CAS 
    PubMed 

    Google Scholar 

  • Zhang LS, Liu C, Ma H, Dai Q, Sun HL, Luo G, et al. Transcriptome-wide Mapping of Internal N(7)-Methylguanosine Methylome in Mammalian mRNA. Mol Cell. 2019;74(1304–1316):e1308.

    Google Scholar 

  • Sas-Chen A, Thomas JM, Matzov D, Taoka M, Nance KD, Nir R, et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature. 2020;583:638–43.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Beiki H, Sturgill D, Arango D, Relier S, Schiffers S, Oberdoerffer S. Detection of ac4C in human mRNA is preserved upon data reassessment. Mol Cell. 2024;84(1611–1625):e1613.

    Google Scholar 

  • Zhang LS, Ju CW, Jiang B, He C. Base-resolution quantitative DAMM-seq for mapping RNA methylations in tRNA and mitochondrial polycistronic RNA. Methods Enzymol. 2023;692:39–54.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Gynecologists ACO: ACOG Practice Bulletin No. 227: Fetal Growth Restriction. Obstetrics Gynecol. 2021;137:754.

  • Gilchrist C, Cumberland A, Walker D, Tolcos M. Intrauterine growth restriction and development of the hippocampus: implications for learning and memory in children and adolescents. Lancet Child Adolesc Health. 2018;2:755–64.

    PubMed 

    Google Scholar 

  • Hoek HW, Susser E, Buck KA, Lumey LH, Lin SP, Gorman JM. Schizoid personality disorder after prenatal exposure to famine. Am J Psychiatry. 1996;153:1637–9.

    CAS 
    PubMed 

    Google Scholar 

  • Chen YY, Zhou LA. The long-term health and economic consequences of the 1959–1961 famine in China. J Health Econ. 2007;26:659–81.

    PubMed 

    Google Scholar 

  • Tsikouras P, Antsaklis P, Nikolettos K, Kotanidou S, Kritsotaki N, Bothou A, et al. Diagnosis, prevention, and management of fetal growth restriction (FGR). J Pers Med. 2024. https://doi.org/10.3390/jpm14070698.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen W, Liu N, Shen S, Zhu W, Qiao J, Chang S, et al. Fetal growth restriction impairs hippocampal neurogenesis and cognition via Tet1 in offspring. Cell Rep. 2021;37:109912.

    CAS 
    PubMed 

    Google Scholar 

  • Veenendaal MVE, Painter RC, de Rooij SR, Bossuyt PMM, van der Post JAM, Gluckman PD, et al. Transgenerational effects of prenatal exposure to the 1944–45 Dutch famine. BJOG. 2013;120:548–54.

    CAS 
    PubMed 

    Google Scholar 

  • Yao WY, Yu YF, Li LH, Xu WH. Exposure to Chinese famine in early life and height across 2 generations: a longitudinal study based on the China Health and Nutrition Survey. Am J Clin Nutr. 2024;119:433–43.

    CAS 
    PubMed 

    Google Scholar 

  • Radford EJ, Ito M, Shi H, Corish JA, Yamazawa K, Isganaitis E, Seisenberger S, Hore TA, Reik W, Erkek S, et al: In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism. Science. 2014;345:785.

  • Zhang ZM, Luo XF, Lv Y, Yan LL, Xu SS, Wang Y, et al. Intrauterine growth restriction programs intergenerational transmission of pulmonary arterial hypertension and endothelial dysfunction via sperm epigenetic modifications. Hypertension. 2019;74:1160–71.

    CAS 
    PubMed 

    Google Scholar 

  • Borchardt EK, Martinez NM, Gilbert WV. Regulation and function of RNA pseudouridylation in human cells. Annu Rev Genet. 2020;54:309–36.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang LS, Ye C, Ju CW, Gao B, Feng X, Sun HL, et al. BID-seq for transcriptome-wide quantitative sequencing of mRNA pseudouridine at base resolution. Nat Protoc. 2024;19:517–38.

    CAS 
    PubMed 

    Google Scholar 

  • Santiago J, Silva JV, Howl J, Santos MAS, Fardilha M. All you need to know about sperm RNAs. Hum Reprod Update. 2021;28:67–91.

    PubMed 

    Google Scholar 

  • Chen Q, Yan W, Duan E. Epigenetic inheritance of acquired traits through sperm RNAs and sperm RNA modifications. Nat Rev Genet. 2016;17:733–43.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Herridge RP, Dolata J, Migliori V, Alves CD, Borges F, Schorn AJ, van Ex F, Lin A, Bajczyk M, Parent JS, et al. Pseudouridine guides germline small RNA transport and epigenetic inheritance. Nat Struct Mol Biol. 2025 Feb;32(2):277-86.

  • Suzuki T. The expanding world of tRNA modifications and their disease relevance. Nat Rev Mol Cell Biol. 2021;22:375–92.

    CAS 
    PubMed 

    Google Scholar 

  • Wang C, Lu CF, Peng J, Hu CD, Wang Y. Roles of neural stem cells in the repair of peripheral nerve injury. Neural Regen Res. 2017;12:2106–12.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wen C, Cao L, Wang S, Xu W, Yu Y, Zhao S, et al. MCM8 interacts with DDX5 to promote R-loop resolution. EMBO J. 2024;43:3044–71.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhai Y, Cheng E, Wu H, Li N, Yung PY, Gao N, et al. Open-ringed structure of the Cdt1-Mcm2-7 complex as a precursor of the MCM double hexamer. Nat Struct Mol Biol. 2017;24:300–8.

    CAS 
    PubMed 

    Google Scholar 

  • Wang P, Ye C, Zhao M, Jiang B, He C. Small-molecule-catalysed deamination enables transcriptome-wide profiling of N(6)-methyladenosine in RNA. Nat Chem. 2025. https://doi.org/10.1038/s41557-025-01801-3.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Sun H, Lu B, Zhang Z, Xiao Y, Zhou Z, Xi L, et al. Mild and ultrafast GLORI enables absolute quantification of m(6)A methylome from low-input samples. Nat Methods. 2025. https://doi.org/10.1038/s41592-025-02680-9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Li Y, Xue J, Ma Y, Ye K, Zhao X, Ge F, et al. The complex roles of m 6 A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases. Neural Regen Res. 2025;20:1582–98.

    CAS 
    PubMed 

    Google Scholar 

  • Lv J, Xing L, Zhong X, Li K, Liu M, Du K. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents. Biomed Pharmacother. 2023;162:114583.

    CAS 
    PubMed 

    Google Scholar 

  • Wan X, Ge Y, Xu S, Feng Y, Zhu Y, Yin L, et al. M(6)a modification and its role in neural development and neurological diseases. Epigenomics. 2023;15:819–33.

    CAS 
    PubMed 

    Google Scholar 

  • Gui Y, Yuan S. Epigenetic regulations in mammalian spermatogenesis: RNA-m(6)a modification and beyond. Cell Mol Life Sci. 2021;78:4893–905.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Lin Z, Hsu PJ, Xing X, Fang J, Lu Z, Zou Q, et al. Mettl3-/Mettl14-mediated mRNA N(6)-methyladenosine modulates murine spermatogenesis. Cell Res. 2017;27:1216–30.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Huang T, Liu ZD, Zheng Y, Feng TY, Gao Q, Zeng WX. YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway. Cell Death Dis. 2020. https://doi.org/10.1038/s41419-020-2235-4.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wu YF, Li JC, Li CMJ, Lu S, Wei XY, Li Y, et al. Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner. J Biol Chem. 2023. https://doi.org/10.1016/j.jbc.2023.104783.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Myers BL, Brayer KJ, Paez-Beltran LE, Villicana E, Keith MS, Suzuki H, et al. Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration. Nat Commun. 2024;15:10363.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hoeck JD, Jandke A, Blake SM, Nye E, Spencer-Dene B, Brandner S, et al. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat Neurosci. 2010;13:1365–72.

    CAS 
    PubMed 

    Google Scholar 

  • Torii MA, Matsuzaki F, Osumi N, Kaibuchi K, Nakamura S, Casarosa S, et al. Transcription factors Mash-1 and Prox-1 delineate early steps in differentiation of neural stem cells in the developing central nervous system. Development. 1999;126:443–56.

    CAS 
    PubMed 

    Google Scholar 

  • Karalay Ö, Doberauer K, Vadodaria KC, Knobloch M, Berti L, Miquelajauregui A, et al. Prospero-related homeobox 1 gene (Prox1) is regulated by canonical Wnt signaling and has a stage-specific role in adult hippocampal neurogenesis. Proc Natl Acad Sci U S A. 2011;108:5807–12.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Salmen F, De Jonghe J, Kaminski TS, Alemany A, Parada GE, Verity-Legg J, et al. High-throughput total RNA sequencing in single cells using VASA-seq. Nat Biotechnol. 2022;40:1780–93.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Turchinovich A, Surowy H, Serva A, Zapatka M, Lichter P, Burwinkel B. Capture and amplification by tailing and switching (CATS). An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA. RNA Biol. 2014;11:817–28.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen C, Xing D, Tan L, Li H, Zhou G, Huang L, et al. Single-cell whole-genome analyses by linear amplification via transposon insertion (LIANTI). Science. 2017;356:189–94.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cui XL, Nie J, Zhu H, Kowitwanich K, Beadell AV, West-Szymanski DC, et al. LABS: linear amplification-based bisulfite sequencing for ultrasensitive cancer detection from cell-free DNA. Genome Biol. 2024;25:157.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Xie R, Yang X, He W, Luo Z, Li W, Xu C, et al. LAMP-MS for locus-specific visual quantification of DNA 5 mC and RNA m(6)A using ultra-low input. Angew Chem Int Ed Engl. 2025;64:e202413872.

    CAS 
    PubMed 

    Google Scholar 

  • Lyu J, Chen C. LAST-seq: single-cell RNA sequencing by direct amplification of single-stranded RNA without prior reverse transcription and second-strand synthesis. Genome Biol. 2023;24:184.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Verboom K, Everaert C, Bolduc N, Livak KJ, Yigit N, Rombaut D, et al. SMARTer single cell total RNA sequencing. Nucleic Acids Res. 2019;47:e93.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Eyler DE, Franco MK, Batool Z, Wu MZ, Dubuke ML, Dobosz-Bartoszek M, et al. Pseudouridinylation of mRNA coding sequences alters translation. Proc Natl Acad Sci U S A. 2019;116:23068–74.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Deogharia M, Mukhopadhyay S, Joardar A, Gupta R. The human ortholog of archaeal Pus10 produces pseudouridine 54 in select tRNAs where its recognition sequence contains a modified residue. RNA. 2019;25:336–51.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Song J, Zhuang Y, Zhu C, Meng H, Lu B, Xie B, et al. Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation. Nat Chem Biol. 2020;16:160–9.

    CAS 
    PubMed 

    Google Scholar 

  • Mukhopadhyay S, Deogharia M, Gupta R. Mammalian nuclear TRUB1, mitochondrial TRUB2, and cytoplasmic PUS10 produce conserved pseudouridine 55 in different sets of tRNA. RNA. 2021;27:66–79.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Behm-Ansmant I, Massenet S, Immel F, Patton JR, Motorin Y, Branlant C. A previously unidentified activity of yeast and mouse RNA:pseudouridine synthases 1 (Pus1p) on tRNAs. RNA. 2006;12:1583–93.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Feinberg JS, Joseph S. Identification of molecular interactions between P-site tRNA and the ribosome essential for translocation. Proc Natl Acad Sci U S A. 2001;98:11120–5.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Helm M, Brule H, Degoul F, Cepanec C, Leroux JP, Giege R, et al. The presence of modified nucleotides is required for cloverleaf folding of a human mitochondrial tRNA. Nucleic Acids Res. 1998;26:1636–43.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang J, Xiong YW, Tan LL, Zheng XM, Zhang YF, Ling Q, et al. Sperm Rhoa m6A modification mediates intergenerational transmission of paternally acquired hippocampal neuronal senescence and cognitive deficits after combined exposure to environmental cadmium and high-fat diet in mice. J Hazard Mater. 2023;458:131891.

    CAS 
    PubMed 

    Google Scholar 

  • Zhou Y, Lian C, Lu Y, Wang T, Zhao C, Zhang C, Gong M, Chen J, Ju R: Maternal androgen exposure induces intergenerational effects via paternal inheritance. J Endocrinol. 2024;262(2):e230368.

  • Mao Y, Meng Y, Zou K, Qin N, Wang Y, Yan J, et al. Advanced paternal age exacerbates neuroinflammation in offspring via m6A modification-mediated intergenerational inheritance. J Neuroinflammation. 2024;21:249.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • He W, Yin X, Xu C, Liu X, Huang Y, Yang C, et al. Ascorbic acid reprograms epigenome and epitranscriptome by reducing Fe(III) in the catalytic cycle of dioxygenases. ACS Chem Biol. 2024;19:129–40.

    CAS 
    PubMed 

    Google Scholar 

  • Hu L, Xu C, He W. Uli-Epic: A cutting-edge library construction strategy for profiling ultra-limited RNA modifications [Uli-Epic BID-seq] Gene Expression Omnibus. 2024. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&acc=GSE277358. 

  • Uli-Epic: A cutting-edge library construction strategy for profiling ultra-limited RNA modifications [Uli-Epic GLORI] Gene Expression Omnibus. 2024. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277359.

  • Hu L, Xu C, He W. Ascorbic acid reprogrames epigenome and epitranscriptome by recycling Fe (III) into Fe (II) in the catalytic cycle of dioxygenases. Gene Expression Omnibus. 2024. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242760. 

Continue Reading

  • Brené Brown on Being a Steady Leader in Tumultuous Times

    Brené Brown on Being a Steady Leader in Tumultuous Times

    ADI IGNATIUS: I am Adi Ignatius.

    ALISON BEARD: I’m Alison Beard, and this is the HBR IdeaCast.

    ADI IGNATIUS So today’s guest is the renowned researcher and author, Brené Brown. It’s probably best known for her work on…

    Continue Reading

  • Chief Justice of Pakistan, Mr. Justice Yahya Afridi, chairs a meeting on the E-Court System across Pakistan at the Supreme Court.

    Chief Justice of Pakistan, Mr. Justice Yahya Afridi, chairs a meeting on the E-Court System across Pakistan at the Supreme Court.

    Chief Justice of Pakistan, Mr. Justice Yahya Afridi, chairs a meeting on the E-Court System across Pakistan at the Supreme Court.

    Continue Reading

  • GNU Coreutils 9.9 brings fixes and updates across essential tools

    GNU Coreutils 9.9 brings fixes and updates across essential tools

    GNU Coreutils is the backbone of many enterprise Linux environments. It provides the basic file, shell, and text utilities that every GNU-based system depends on. The latest release, version 9.9, refines these tools with fixes and…

    Continue Reading

  • At 3 Years, Eque-Cel Displays Deep and Durable Responses in Relapsed Multiple Myeloma

    At 3 Years, Eque-Cel Displays Deep and Durable Responses in Relapsed Multiple Myeloma

    The therapeutic landscape of relapsed or refractory multiple myeloma has evolved rapidly with the advent of BCMA-directed cellular therapies, offering the possibility of deep and durable responses in a setting historically characterized by diminishing treatment returns with each subsequent line of therapy. However, questions have remained regarding long-term durability, late relapse, and safety with extended follow-up. Updated 3-year results from the phase 1b/2 FUMANBA-1 trial (NCT05066646; CTR20192510) presented by investigators from the China Academy of Chinese Medical Sciences at the 22nd Annual International Myeloma Society (IMS) Meeting and Exposition begin to address these gaps.1

    In the study, equecabtagene autoleucel (eque-cel; Fucaso), a fully human anti-BCMA CAR T-cell therapy, continued to demonstrate sustained clinical activity at a median follow-up of 36 months. Among 107 efficacy-evaluable patients, the objective response rate (ORR) reached 96.3%, including an 83.2% complete response (CR) or better rate. In CAR T-cell therapy–naive patients (n = 95), outcomes were even more pronounced, with ORR and CR rates of 98.9% and 88.4%, respectively. The median progression-free survival (PFS) was 30.46 months (95% CI, 24.11-42.15) in the overall population, extending to 39.82 months (95% CI, 30.26-not reached) among patients achieving at least a CR and 35.91 months (95% CI, 25.95-47.67) among those without prior CAR T-cell therapy. The median overall survival (OS) had not yet been reached, with 66.3% of patients alive at 3 years.

    “Eque-cel is an excellent product, and I hope it [will] benefit patients around the world,” lead study author Lugui Qiu, MD, shared in an interview with OncLive®, where he expanded on the clinical significance of these results, the durability of responses observed with eque-cel, and how these data inform the positioning of BCMA-directed CAR T-cell therapy in contemporary myeloma treatment sequencing.

    Qiu is part of the National Clinical Research Center for Blood Diseases, the State Key Laboratory of Experimental Hematology, and the Blood Diseases Hospital & Institute of Hematology at the Chinese Academy of Medical Sciences & Peking Union Medical College.

    OncLive: How was the phase 1b/2 FUMANBA-1 trial designed?

    Qiu: The study was designed as a registrational trial that evaluated eque-cel, a fully human anti-BCMA CAR-T cell therapy originally from a biotech [company] in China. This study started in 2019, and the enrollment finished in 1 year, so it went well.

    On June 30, 2023, eque-cel was approved by China’s National Medical Products Administration for relapsed and refractory multiple myeloma patients who had received at least 3 lines of prior therapy, including at least 1 proteasome inhibitor and an immunomodulatory drug [IMiD].2

    What long-term findings were presented at IMS?

    There were a total of 109 patients enrolled in this clinical trial, and 107 patients were efficacy evaluable. The total response rate was [96.3]%, and the CR [or better] rate was [83.2]%. We enrolled 12 patients who had received prior BCMA-directed CAR-T therapy. For those patients, the total response rate was 75%, with a median PFS of [approximately] 1 year. For patients without prior BCMA-directed CAR T-cell therapy, the total response was [98.9]%, and the CR rate was [88.4]%.

    After a median follow-up of 3 years, in the whole group, the median PFS was [30.46] months. For the 95 patients without prior CAR-T therapy, the median PFS was [35.91] months, and the median OS was not yet reached. [In total], 66.3% of patients were still alive at the 3-year follow-up.

    What was observed with regard to the safety profile?

    The safety profile is [good]. During the trial, [93.6]% of patients [experienced CRS], but mostly grade 1 or grade 2. Only 1 patient experienced grade 3 CRS, and there were only 2 patients who [developed] ICANS. There were no toxicity-related deaths in this trial.

    Several commercial BCMA-directed CAR-T therapies are [available globally]. In my impression, eque-cel has efficacy comparable with ciltacabtagene ciloleucel, and the safety profile is better than idecabtagene vicleucel. Eque-cel is a good product balancing [both] the efficacy and safety profiles.

    What are the next steps for analyzing eque-cel in patients with relapsed/refractory multiple myeloma?

    We have also launched a real-world study of eque-cel in relapsed and refractory multiple myeloma following market approval. [At IMS, we had] a poster reporting 150 cases from this real-world study. The results show that the efficacy and safety profile in the real-world setting were similar to [those in] our clinical trial.

    This product has benefited many heavily pretreated patients, including those previously treated with proteasome inhibitors, IMiDs, anti-CD38 antibodies, and even some patients who had prior BCMA-directed CAR T-cell therapy. [These patients] can still benefit from eque-cel.

    References

    1. Li C, Zou D, Zhou K, et al. Three-year follow-up of FUMANBA-1: a phase 1b/2 study of fully human anti-BCMA CAR-T equecabtagene autoleucel in patients with relapsed/refractory multiple myeloma. Presented at the 22nd Annual International Myeloma Society Meeting and Exposition; September 17-20, 2025; Toronto, Canada. Abstract OA-08.
    2. Innovent and IASO Bio announce the NMPA approval of Fucaso, the first fully-human BCMA CAR-T therapy for the treatment of relapsed or refractory multiple myeloma. News release. Innovent Biologics, Inc. July 3, 2023. Accessed November 11, 2025. https://www.iasobio.com/info.php?id=224

    Continue Reading

  • Cristiano Ronaldo Confirms the 2026 World Cup Will Be the Last of His Career – beIN SPORTS

    1. Cristiano Ronaldo Confirms the 2026 World Cup Will Be the Last of His Career  beIN SPORTS
    2. Ronaldo confirms 2026 World Cup will be his last  BBC
    3. Ronaldo clarifies ‘soon’ means one or two years before retirement  Dawn
    4. Cristiano Ronaldo plans to…

    Continue Reading

  • Suicide bomber struck outside an Islamabad court, killing 12, minister says

    Suicide bomber struck outside an Islamabad court, killing 12, minister says

    ISLAMABAD (AP) — A suicide bomber struck outside the gates of a district court in Islamabad on Tuesday, detonating his explosives next to a police car and killing 12 people, Pakistan’s interior…

    Continue Reading

  • Key antenna in NASA’s Deep Space Network damaged

    Key antenna in NASA’s Deep Space Network damaged

    WASHINGTON — One of the largest antennas in NASA’s Deep Space Network was damaged in September and may be out of service for an extended period, further straining the system.

    NASA’s Jet Propulsion Laboratory confirmed Nov. 10…

    Continue Reading

  • Midlife blood test may reveal Alzheimer’s disease risk in advance

    Midlife blood test may reveal Alzheimer’s disease risk in advance

    A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer’s disease decades ahead of time, allowing for possible preventive therapy.

    The blood-clotting process in vascular…

    Continue Reading